These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36443397)

  • 1. Correction: EZH2 overexpression dampens tumor-suppressive signals via an EGR1 silencer to drive breast tumorigenesis.
    Guan X; Deng H; Choi UL; Li Z; Yang Y; Zeng J; Liu Y; Zhang X; Li G
    Oncogene; 2023 Jan; 42(1):78. PubMed ID: 36443397
    [No Abstract]   [Full Text] [Related]  

  • 2. EZH2 overexpression dampens tumor-suppressive signals via an EGR1 silencer to drive breast tumorigenesis.
    Guan X; Deng H; Choi UL; Li Z; Yang Y; Zeng J; Liu Y; Zhang X; Li G
    Oncogene; 2020 Nov; 39(48):7127-7141. PubMed ID: 33009487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.
    Crawford NT; McIntyre AJ; McCormick A; D'Costa ZC; Buckley NE; Mullan PB
    Oncogene; 2019 Aug; 38(31):5971-5986. PubMed ID: 31253870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2-mediated Epigenetic Silencing of miR-29/miR-30 targets LOXL4 and contributes to Tumorigenesis, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.
    Yin H; Wang Y; Wu Y; Zhang X; Zhang X; Liu J; Wang T; Fan J; Sun J; Yang A; Zhang R
    Theranostics; 2020; 10(19):8494-8512. PubMed ID: 32754259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifaceted role of EZH2 in breast and prostate tumorigenesis: epigenetics and beyond.
    Deb G; Thakur VS; Gupta S
    Epigenetics; 2013 May; 8(5):464-76. PubMed ID: 23644490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-33a functions as a tumor suppressor in triple-negative breast cancer by targeting EZH2.
    Weihua Z; Guorong Z; Xiaolong C; Weizhan L
    Cancer Cell Int; 2020; 20():85. PubMed ID: 32206036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-377-3p-Mediated EGR1 Downregulation Promotes B[a]P-Induced Lung Tumorigenesis by Wnt/Beta-Catenin Transduction.
    Ke X; He L; Wang R; Shen J; Wang Z; Shen Y; Fan L; Shao J; Qi H
    Front Oncol; 2021; 11():699004. PubMed ID: 34497759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2.
    Lu J; He ML; Wang L; Chen Y; Liu X; Dong Q; Chen YC; Peng Y; Yao KT; Kung HF; Li XP
    Cancer Res; 2011 Jan; 71(1):225-33. PubMed ID: 21199804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEK-ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes.
    Fujii S; Tokita K; Wada N; Ito K; Yamauchi C; Ito Y; Ochiai A
    Oncogene; 2011 Sep; 30(39):4118-28. PubMed ID: 21499305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EZH2 inhibition sensitizes tamoxifen‑resistant breast cancer cells through cell cycle regulation.
    Chen S; Yao F; Xiao Q; Liu Q; Yang Y; Li X; Jiang G; Kuno T; Fang Y
    Mol Med Rep; 2018 Feb; 17(2):2642-2650. PubMed ID: 29207119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rottlerin inhibits cell growth and invasion via down-regulation of EZH2 in prostate cancer.
    Zheng N; Wang L; Hou Y; Zhou X; He Y; Wang Z
    Cell Cycle; 2018; 17(21-22):2460-2473. PubMed ID: 30394832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early growth response gene 1 modulates androgen receptor signaling in prostate carcinoma cells.
    Yang SZ; Abdulkadir SA
    J Biol Chem; 2003 Oct; 278(41):39906-11. PubMed ID: 12890669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer.
    Mahara S; Lee PL; Feng M; Tergaonkar V; Chng WJ; Yu Q
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3735-44. PubMed ID: 27303043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features.
    Guo S; Li X; Rohr J; Wang Y; Ma S; Chen P; Wang Z
    Diagn Pathol; 2016 Apr; 11():41. PubMed ID: 27113214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial role for early growth response-1 in the transcriptional regulation of miR-20b in breast cancer.
    Li D; Ilnytskyy Y; Kovalchuk A; Khachigian LM; Bronson RT; Wang B; Kovalchuk O
    Oncotarget; 2013 Sep; 4(9):1373-87. PubMed ID: 23945289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells.
    Zeidler M; Varambally S; Cao Q; Chinnaiyan AM; Ferguson DO; Merajver SD; Kleer CG
    Neoplasia; 2005 Nov; 7(11):1011-9. PubMed ID: 16331887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer.
    Zhang H; Zhang H; Zhao M; Lv Z; Zhang X; Qin X; Wang H; Wang S; Su J; Lv X; Liu H; Du W; Zhou W; Chen X; Fei K
    Cell Physiol Biochem; 2013; 31(1):56-65. PubMed ID: 23343715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGR1 Regulates Transcription Downstream of Mechanical Signals during Tendon Formation and Healing.
    Gaut L; Robert N; Delalande A; Bonnin MA; Pichon C; Duprez D
    PLoS One; 2016; 11(11):e0166237. PubMed ID: 27820865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-33b Suppresses Epithelial-Mesenchymal Transition Repressing the MYC-EZH2 Pathway in HER2+ Breast Carcinoma.
    Pattanayak B; Garrido-Cano I; Adam-Artigues A; Tormo E; Pineda B; Cabello P; Alonso E; Bermejo B; Hernando C; Martínez MT; Rovira A; Albanell J; Rojo F; Burgués O; Cejalvo JM; Lluch A; Eroles P
    Front Oncol; 2020; 10():1661. PubMed ID: 33014831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulforaphene inhibits triple negative breast cancer through activating tumor suppressor Egr1.
    Yang M; Teng W; Qu Y; Wang H; Yuan Q
    Breast Cancer Res Treat; 2016 Jul; 158(2):277-86. PubMed ID: 27377973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.